40 million more women would lose access to abortion care if a federal court revokes the use of a key drug in medication abortions, data from the abortion rights group NARAL shows.
Why it matters: A U.S. District Court in Texas could decide this month to temporarily block the FDA's authorization of mifepristone, one of two drugs used to end pregnancies. Doing so would effectively result in a nationwide ban on a method that accounts for most abortions in the U.S.
